本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atara Biotherapeutics

5.01
+0.30006.37%
盤後5.190.1800+3.59%16:41 EDT
成交量:12.16萬
成交額:60.96萬
市值:4,097.24萬
市盈率:1.95
高:5.20
開:4.91
低:4.73
收:4.71
52周最高:19.15
52周最低:3.92
股本:817.81萬
流通股本:560.06萬
量比:2.20
換手率:2.17%
股息:- -
股息率:- -
每股收益(TTM):2.57
每股收益(LYR):-11.4053
淨資產收益率:-2014.86%
總資產收益率:47.81%
市淨率:-1.06
市盈率(LYR):-0.44

資料載入中...

2025/01/16

重要事件披露

Form 8-K - Current report
2024/12/23

重要事件披露

Form 8-K - Current report
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/05

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]